Flat Footed, one of Grifols’ non-family shareholders, joined hedge fund Mason Capital Management LLC in calling for an ...

For hedge fund Mason Capital Management LLC, much of what ails Grifols SA can be laid at the door of one man: Tomas Daga. But for the drugmaker, he’s someone who’s helped transform the once-tiny ...

Law firm Araoz y Rueda has been independently engaged by several international and Spanish institutions (the "Clients") holding in aggregate 5.65% of A shares and 3.88% of B shares (including ADRs) in ...

Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...

Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial ...

The accusations are the latest antitrust headache for the tech giant. The decision ends three of the EU competition regulator's attempts to crack down on international companies' tax deals.

European markets were higher Thursday, rallying after a day in the doldrums during the previous session. The pan-European ...

Sky News has learnt that Barclays and Brookfield, the Canadian asset management giant, are in detailed talks about a deal that would involve the British lender retaining a 20% stake in the division.

The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...

Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...